Leukoaraiosis: From an ancient term to an actual marker of poor prognosis

Stroke

Volumn 39, Issue 5, 2008, Pages 1401-1403

  Pantoni, Leonardo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINSWANGER ENCEPHALOPATHY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; GERIATRIC PATIENT; HUMAN; LEUKOARAIOSIS; MORTALITY; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; WHITE MATTER; AGING; BRAIN; BRAIN INFARCTION; DISEASE COURSE; EARLY DIAGNOSIS; MULTIINFARCT DEMENTIA; MYELINATED NERVE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; VASCULARIZATION;

BIOLOGICAL MARKER;

AGING; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; COGNITION DISORDERS; DEMENTIA, VASCULAR; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; LEUKOARAIOSIS; NERVE FIBERS, MYELINATED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 44449149915     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.505602     Document Type: Editorial

References (29)

1. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci. 1986;13(4 Suppl):533-534.
2. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987; 44:21-23.
3. George AE, de Leon MJ, Gentes CI, Miller J, London E, Budzilovich GN, Ferris S, Chase N. Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies. AJNR Am J Neuroradiol. 1986;7:561-566.
4. Pullicino P, Eskin T, Ketonen L. Prevalence of Binswanger's disease. Lancet. 1983;1:939.
5. Roman GC. Why not Binswanger's disease? Arch Neurol. 1988;45: 141-143.
6. Johnson KA, Davis KR, Buonanno FS, Brady TJ, Rosen TJ, Growdon JH. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Arch Neurol. 1987;44:1075-1080.
7. George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N. Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol. 1986;7:567-570.
8. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol. 1989; 29:164-168.
9. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke. 1995;26: 1293-1301.
10. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke. 1996;27: 1274-1282.
11. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70:9-14.
12. Guttmann CR, Benson R, Warfield SK, Wei X, Anderson MC, Hall CB, Abu-Hasaballah K, Mugler JP III, Wolfson L. White matter abnormalities in mobility-impaired older persons. Neurology. 2000; 54:1277-1283.
13. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkin-juntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bazner H, Inzitari D; on behalf of the LADIS Group. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007;191:212-217.
14. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 2000;31:2182-2188.
15. Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurol. 2007;20:390-397.
16. Wen HM, Mok VC, Fan YH, Lam WW, Tang WK, Wong A, Huang RX, Wong KS. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke. 2004;35:1826 -1830.
17. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36: 2116-2120.
18. van der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund LO, Rostrup E, Schmidt R, Fazekas F, Scheltens P, for the LADIS study group. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry. 2005;76:1497-1500.
19. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke. 2007;38:2619 -2625.
20. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F, for the Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet. 2003;361: 2046-2048.
21. Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology. 2007;68: 214-222.
22. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L. Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry. 1997;62:177-181.
23. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology. 2000;54:90-94.
24. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531-1534.
25. Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Barkhof F, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L, for the LADIS Study Group. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med. 2007;167:81-88.
26. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A, Kucinski T, Lecei O, Liebeskind DS, Rother J, Rosso C, Samson Y, Saver JL, Yan B, for the MR Stroke Group. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke. 2006;37:2463-2466.
27. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM, for the CASES Investigators. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007;68:1020-1024.
28. Ay H, Arsava EM, Rosand J, Furie KL, Singhal AB, Schaefer PW, Wu O, Gonzalez RG, Koroshetz WJ, Sorensen AG. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke. 2008;39: 1409-1413.
29. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, Barkhof F, Fazekas F, for the European Task Force on Age-Related White Matter Changes. White matter lesion progression. A surrogate endpoint for trials in cerebral small vessel disease. Neurology. 2004;63:139-144.